(Q73203629)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093709%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Adjuvant chemotherapy (5-fluorouracil and levamisole) in Dukes' B and C colorectal carcinoma. A cost-effectiveness analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093709%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1 reference

J Norum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093709%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

B Vonen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093709%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J A Olsen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093709%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Revhaug

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093709%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093709%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093709%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093709%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093709%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

65-70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093709%20AND%20SRC:MED&resulttype=core&format=json

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265905933

7 January 2021

Adjuvant therapy of colorectal cancer. Why we still don't know

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265905933

7 January 2021

AXIS--a suitable case for treatment. UK Coordinating Committee on Cancer Research (UKCCCR) Colorectal Cancer Subcommittee

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265905933

7 January 2021

The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265905933

7 January 2021

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265905933

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265905933

7 January 2021

Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265905933

7 January 2021

Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265905933

7 January 2021

Effective surgical adjuvant therapy for high-risk rectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265905933

7 January 2021

Should patients with Dukes' C colon cancer receive adjuvant chemotherapy after curative resection?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265905933

7 January 2021

Adjuvant therapy for colon and rectal cancer. NIH Consensus Development Conference

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265905933

7 January 2021

The chemotherapy of colon cancer can no longer be ignored

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265905933

7 January 2021

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265905933

7 January 2021

European School of Oncology Advisory report to the Commission of the European Communities for the "Europe Against Cancer Programme" cost-effectiveness in cancer care.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265905933

7 January 2021

Treatment costs in Hodgkin's disease: a cost-utility analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265905933

7 January 2021

Identifiers

DOI

10.1023/A:1008265905933

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9093709%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference